# Clarithromycin synergizes with cisplatin to inhibit ovarian cancer growth in vitro and in vivo

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/clarithromycin-synergizes-with-cisplatin-to-inhibit-ovarian-cancer-growth-in/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Bo Zhou,Meng Xia,Bin Wang,Niresh Thapa,Lijuan Gan,Chaoyang Sun,Ensong Guo,Jia Huang,Yulan Lu,Hongbin Cai |
| Citations | 20 |
| DOI | 10.1186/s13048-019-0570-9 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine,Pharmacology, Toxicology and Pharmaceutics |
| Open Access | true |
| OA Status | gold |
| OA URL | https://ovarianresearch.biomedcentral.com/track/pdf/10.1186/s13048-019-0570-9 |
| OpenAlex ID | https://openalex.org/W2987457507 |
| PMID | 31703731 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Hongbin Cai](https://scholariq.org/researchers/hongbin-cai/)

## Paper primary topic

- [Cancer therapeutics and mechanisms](https://scholariq.org/topics/cancer-therapeutics-and-mechanisms/)

## Paper topics

- [Cancer therapeutics and mechanisms](https://scholariq.org/topics/cancer-therapeutics-and-mechanisms/)
- [Chemotherapy-induced organ toxicity mitigation](https://scholariq.org/topics/chemotherapy-induced-organ-toxicity-mitigation/)
- [Bioactive Compounds and Antitumor Agents](https://scholariq.org/topics/bioactive-compounds-and-antitumor-agents/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.